Gracell Biotechnologies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRCL and other ETFs, options, and stocks.

About GRCL

Gracell Biotechnologies, Inc. engages in the research and development activities of biotechnological and pharmaceutical industries. The firm through its FasTCAR and TruUCAR platforms, it is developing a pipeline of autologous and allogeneic cell therapy candidates with the potential to treat both hematologic malignancies and solid tumors. 

CEO
Wei Cao
CEOWei Cao
Employees
348
Employees348
Headquarters
Suzhou, Shanghai
HeadquartersSuzhou, Shanghai
Founded
2017
Founded2017
Employees
348
Employees348

GRCL Key Statistics

Market cap
245.17M
Market cap245.17M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
60.83K
Average volume60.83K
High today
$3.59
High today$3.59
Low today
$3.10
Low today$3.10
Open price
$3.43
Open price$3.43
Volume
19.46K
Volume19.46K
52 Week high
$15.00
52 Week high$15.00
52 Week low
$1.68
52 Week low$1.68

GRCL Earnings

-$0.35
-$0.23
-$0.12
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.